Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department
FDA inspection history in Houston, Texas, 2026
- 1
- Form 483
Every document, by year
- Form 483
2026: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2026One Form 483, at Houston, Texas.
Cited most
Across all Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department observations on file
- 21 CFR 312.60General responsibilities of investigators1
The complete Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Houston, Texas
One Form 483 · 2026 · 1 observation
Latest: Form 483, Apr 30, 2026 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2026-04-30 | 483 Form 483 | Houston, Texas | 1 | $99 |
Investigators on these documents
FEI number 3043129636 · most recent document Apr 30, 2026
About Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department
How many FDA Form 483s has Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department received?
FDA Intel has 1 Form 483 on file for Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department; the most recent is dated Apr 30, 2026.
When was Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department last inspected by FDA?
The most recent FDA inspection document on file for Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department is a Form 483 dated Apr 30, 2026, for the site in Houston, Texas.
What did FDA cite at Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department?
The regulations cited most in the observations on file for Prithviraj Bose, M.D. M.D. Anderson Cancer Center, Department are 21 CFR 312.60 (General responsibilities of investigators), 1 time.